跳至主要内容
临床试验/JPRN-UMIN000044985
JPRN-UMIN000044985已完成未知

Efficacy trial of 4 weeks ingestion of MSHF001 food - Efficacy trial of 4 weeks ingestion of MSHF001 food

Kao Corporation0 个研究点目标入组 60 人开始时间: 2021年7月30日最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40years-old 至 59years-old(—)
性别
Female

入选标准

  • 未提供

排除标准

  • -Subjects who are hot flashes 7 times a day or more, or 50 times a week or more. -Subjects with Kupperman index of 44 or higher. -Subjects with systemic illness. -Subjects who are diagnosed as menopausal disorders. -Subjects who are under Hormone Replacement Therapy (HRT). -Subjects who are outpatients or were treated by doctor within a month. -Subjects who are antidepressants, anxiolytics, hypnotic sedatives, taking drugs that affect psychiatric symptoms. -Subjects who have taken drugs or supplements (products mainly made with equol, isoflavones, and polyphenol-rich) that affect menopausal symptoms from 4 weeks before the screening trial. -Subjects who have been taking drugs or prescription drugs that affect the trial since 4 weeks before the start of the screening trial. -Subjects who are pregnant or lactating, or planned to become pregnant in the near future. -Subjects with smoking habit. -Subjects with drinking habit in every days (Alcohol equivalent 20g/day or more). -Subjects who have significantly disrupted the rhythm of their lives during the study period. -Subjects who have possibilities for emerging allergy to the ingredients contained in the test food, subjects with allergies such as drug allergy. -Subjects who plan to participate in other surveys or clinical trials between the time of recruitment and the end of the trial. -Subjects or their families engaged in the manufacture of health foods or supplements , market research company. -Subjects judged not appropriate by the physician responsible for the study.

研究者

相似试验